Key Highlights
- Bryan Haardt appointed as Chief Executive Officer of Eyenuk.
- Paul Praino resumes role as Chief Commercial Officer.
- EyeArt® AI system screens over 300,000 patients since 2020.
- Eyenuk’s AI solutions ensure timely diagnosis of vision-threatening diseases.
Source: PR Newswire
Notable Quotes
- “I’m deeply honored to join Eyenuk and lead the next phase of our journey to ensure timely diagnosis of vision-threatening and life-threatening diseases through the Company’s solutions.” — Bryan Haardt, Chief Executive Officer at Eyenuk
- “On behalf of the Board of Directors, we are excited to welcome Bryan and believe he is the ideal operating leader to shepherd Eyenuk into its next stage of commercial growth.” — Rob Binney, Executive Chairman at Eyenuk
SoHC's Take
The appointment of Bryan Haardt as CEO marks a pivotal moment for Eyenuk. With his extensive background in healthcare technology and digital therapeutics, Haardt is well-positioned to drive the company’s mission of leveraging AI for autonomous disease detection. His leadership is expected to bolster Eyenuk’s innovative AI solutions, particularly the EyeArt® AI system, in expanding their global reach and ensuring timely diagnosis and treatment of vision-threatening diseases. This strategic move aligns with Eyenuk’s goal to enhance patient outcomes through advanced AI technology.
